View live charts, options flow & technicals for Stryker Corporation →
Open Dashboard
Stryker Corporation (SYK) is a healthcare company in the medical devices industry with $25.84B in trailing revenue trading at a 28.4× trailing P/E — analyst consensus: buy.
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
Key Statistics
Market Cap
$105.52B
Revenue (TTM)
$25.84B
EPS (TTM)
$9.68
EPS (Fwd est.)
$16.72
Employees
56,000
Trailing P/E
28.42
Forward P/E
16.45
PEG Ratio
1.28
Price / Sales
4.08
Price / Book
4.40
EV / EBITDA
15.93
Beta (5Y)
0.77
Analyst Consensus
Consensus
Buy
Analyst Price Target
+34.1% upside
Target: $369.00
Annual Revenue & Net Income
RevenueNet Income
'22
$18.45B
$2.36B
'23
$20.50B
$3.17B
'24
$22.59B
$2.99B
'25
$25.12B
$3.25B
Earnings History
Quarter
Actual EPS
Estimate
Result
Jul 2026
$3.69
$3.49
Beat (+5.8%)
Apr 2026
$2.60
$2.98
Miss (-12.9%)
Jan 2026
$4.47
$4.40
Beat (+1.7%)
Oct 2025
$3.19
$3.13
Beat (+1.9%)
Next Earnings Report
Stryker Corporation is next expected to report earnings on 29 Oct 2026.
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment a…
What is SYK's market cap?
Stryker Corporation has a market capitalization of approximately $105.52B.
What is SYK's P/E ratio?
Stryker Corporation trades at a trailing P/E ratio of 28.4x and a forward P/E of 16.4x, which is above the broad market average of ~25x.
How much revenue does SYK generate?
Stryker Corporation generated $25.84B in trailing 12-month revenue.
What do analysts say about SYK?
The analyst consensus rating for Stryker Corporation is buy, with a mean price target of $369.00. That implies +34.1% upside from the current price.
When does SYK report earnings?
Stryker Corporation is next scheduled to report earnings on 29 Oct 2026.
Does SYK pay a dividend?
Yes. Stryker Corporation pays a dividend with a current yield of 1.28%, at an annual rate of $3.52 per share.
View live charts, options flow, gamma exposure, earnings history, and technical analysis for Stryker Corporation on Apsis Markets.